cervical cancer

News

Seagen and Genmab file 'trojan horse' drug with FDA for cerv...

Seagen and Genmab have announced they have filed their antibody-drug conjugate tisotumab vedotin with the FDA for patients with recurrent or metastatic cervical cancer.

News

AI device could be cheaper and more accurate than smear test...

UK startup Lancor Scientific has secured funding to launch a medical device that aims to use artificial intelligence (AI) to detect cervical cancer with 90% accuracy and at lower cost than

News

FDA approves Keytruda in cervical cancer

Merck & Co’s blockbuster Keytruda has been approved in advanced second line cervical cancer, becoming the first drug in its class approved in the indication.

Seagen and Genmab file 'trojan horse' drug with FDA for cerv...

AI device could be cheaper and more accurate than smear test...

FDA approves Keytruda in cervical cancer

LSX2026: Addressing adult eye cancer, with Roi Raz

Using AI-driven synthetic personas to take your insights fur...

Editor's Picks